China’s Sinovac COVID-19 vaccine obtains marketing authorization in Tunisia

0
92
SAO PAULO, BRAZIL - JANUARY 18: A nurse administers a dose of the CoronaVac vaccine to a medical worker at Hospital das Clinicas of the University of Sao Paulo (USP) on January 18, 2021 in Sao Paulo, Brazil. The CoronaVac vaccine was developed by the Chinese laboratory Sinovac in partnership with the Butantan Institute. (Photo by Miguel Schincariol/Getty Images)
SAO PAULO, BRAZIL – JANUARY 18: A nurse administers a dose of the CoronaVac vaccine to a medical worker at Hospital das Clinicas of the University of Sao Paulo (USP) on January 18, 2021 in Sao Paulo, Brazil. The CoronaVac vaccine was developed by the Chinese laboratory Sinovac in partnership with the Butantan Institute. (Photo by Miguel Schincariol/Getty Images)

The Tunisian Ministry of Health announced Thursday that the Chinese Sinovac COVID-19 vaccine has been officially approved for marketing in Tunisia.

“The promotion license was granted after evaluating the file submitted by the Chinese laboratory by the National Laboratory for the Control of Medicines and National Center for Pharmacovigilance with the contribution of other experts in the fields of virology, toxicology, immunology and infectious diseases in Tunisia,” according to a ministry statement.

“This arrangement will allow the acceleration of the process of acquiring the vaccine,” it read.

Leave a Reply